James R Tobin's Net Worth
$116 Million
Who is James R Tobin?
James R Tobin has an estimated net worth of $116 Million. This is based on reported shares across multiple companies, which include GLOBUS MEDICAL INC, TransMedics Group, Inc., Oxford Immunotec Global PLC, Corindus Vascular Robotics, Inc., Lyra Therapeutics, Inc., BOSTON SCIENTIFIC CORP, CHIASMA, INC, CURIS INC, and APPLIED BIOSYSTEMS INC..
SEC CIK
James R Tobin's CIK is 0001190128
Past Insider Trading and Trends
2004 was James R Tobin's most active year for acquiring shares with 18 total transactions. James R Tobin's most active month to acquire stocks was the month of May. 2004 was James R Tobin's most active year for disposing of shares, totalling 190 transactions. James R Tobin's most active month to dispose stocks was the month of March. 2004 saw James R Tobin paying a total of $7,161,593.03 for 1,126,588.3 shares, this is the most they've acquired in one year. In 2004 James R Tobin cashed out on 2,536,300 shares for a total of $58,453,939.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
$56.47 | -$159,413.37 |
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$57.12 | -$392,033.28 |
0
|
Mar 8 - Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
$57.86 | -$704,750.00 |
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
$41.56 | -$171,248.00 |
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
$40.34 | -$489,462.00 |
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
$36.42 | -$826,736.00 |
0
|
Feb 26 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TransMedics Group, Inc. (TMDX) Snapshot price: $87.845
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.86% | -12.03K |
$125.05 | -$1,503,686.50 | 193.15K |
May 3
| |||
Form 4
| -6.83% | -15.04K |
$106.43 | -$1,600,632.76 | 205.17K |
May 1
| |||
Form 4
| -5.73% | -13.38K |
$83.63 | -$1,118,954.54 | 220.21K |
Mar 1
| |||
Form 4
| -4.11% | -10.00K |
$70.14 | -$701,400.00 | 233.59K |
Nov 28
| |||
Form 4
|
∞
| 1.19K |
—
|
—
| 1.19K |
May 25
| |||
Form 4
| -3.94% | -10.00K |
$75.13 | -$751,300.00 | 243.59K |
Scheduled
|
Feb 23
| ||
Form 4
| -16.06% | -48.52K |
$39.98 | -$1,939,629.70 | 253.59K |
Scheduled
|
Jul 29
| ||
Form 4
| -13.84% | -48.52K |
$35.00 | -$1,698,025.00 | 302.11K |
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -12.16% | -48.52K |
$29.94 | -$1,452,569.04 | 350.62K |
Scheduled
|
May 4
| ||
Form 4
| -6.01% | -25.50K |
—
|
—
| 399.14K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -2.34% | -10.17K |
$32.83 | -$333,786.40 | 424.64K |
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| -13.04% | -65.19K |
—
|
—
| 434.81K |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oxford Immunotec Global PLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.08K |
$22.00 | -$89,782.00 |
0
|
Mar 8
| |||
Form 4
|
∞
| 4.08K |
—
|
—
| 4.08K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
| No matching records found | |||||||||
Corindus Vascular Robotics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -106.11K |
$4.28 | -$454,159.36 |
0
|
Oct 29
| |||
Form 4
| +1.11% | 1.17K |
$4.27 | $4,995.90 | 106.11K |
Oct 7
| |||
Form 4
| +1.40% | 1.45K |
$3.44 | $4,998.32 | 104.94K |
Jul 8
| |||
Form 4
| +36.46% | 27.65K |
$2.17 | $59,998.33 | 103.49K |
May 3
| |||
Form 4
| +3.21% | 2.36K |
$2.12 | $4,998.96 | 75.84K |
Apr 5
| |||
Form 4
| +6.47% | 4.46K |
$1.12 | $4,999.68 | 73.48K |
Jan 8
| |||
Form 4
| +4.86% | 3.2K |
$1.25 | $4,000.00 | 69.02K |
Oct 5
| |||
Form 4
| +6.94% | 4.27K |
$1.17 | $4,999.41 | 65.82K |
Jul 9
| |||
Form 4
| +648.81% | 53.33K |
$0.75 | $39,999.83 | 61.55K |
May 31
| |||
Form 4
|
∞
| 8.22K |
—
|
—
| 8.22K |
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||